Woodline Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Buy
359,721
+85,778
+31% +$4.41M 0.05% 405
2026
Q1
$16.2M Buy
+273,943
New +$17.8M 0.06% 383
2024
Q4
Sell
-95,453
Closed -$6.88M 977
2024
Q3
$6.88M Buy
95,453
+27,405
+40% +$1.94M 0.06% 347
2024
Q2
$4.69M Buy
+68,048
New +$4.61M 0.04% 346
2023
Q3
Sell
-38,334
Closed -$2.28M 702
2023
Q2
$2.28M Buy
+38,334
New +$2.29M 0.03% 413
2022
Q1
Sell
-138,038
Closed -$8.37M 799
2021
Q4
$8.37M Buy
138,038
+71,550
+108% +$4.25M 0.12% 219
2021
Q3
$3.73M Buy
+66,488
New +$3.65M 0.06% 301

Other funds holding PBH

Woodline Partners's PBH Position: Q2 2026 in Review

Woodline Partners increased its Prestige Consumer Healthcare (PBH) stake by 31% in Q2 2026, buying an estimated $4.41M and bringing the position to 359,721 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #405.

Woodline Partners first reported a position in PBH in Q3 2021 and has held it in 7 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Woodline Partners held 359,721 shares of Prestige Consumer Healthcare worth $17M as of Q2 2026.
  • Woodline Partners bought 85,778 Prestige Consumer Healthcare shares in Q2 2026, an estimated $4.41M.
  • Prestige Consumer Healthcare made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #405 holding.
  • Woodline Partners first reported a position in Prestige Consumer Healthcare in Q3 2021 and has held it in 7 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.